People: Moody's Corp (MCO)

MCO on New York Consolidated

91.69USD
25 Jul 2014
Price Change (% chg)

$-0.79 (-0.85%)
Prev Close
$92.48
Open
$94.30
Day's High
$95.00
Day's Low
$90.56
Volume
1,160,717
Avg. Vol
879,409
52-wk High
$95.00
52-wk Low
$62.95

Search Stocks

McKinnell, Henry 

Brief Biography

Dr. Henry A. McKinnell, Jr., Ph.D., is Independent Chairman of the Board of Moody's Corp. Dr. McKinnell served as the Chief Executive Officer of Optimer Pharmaceuticals, Inc. from February 2013 until October 31, 2013. He served as Chairman of the Board of Pfizer Inc., a pharmaceutical company, from May 2001 until his retirement in December 2006 and Chief Executive Officer from January 2001 to July 2006. He served as President of Pfizer Inc. from May 1999 to May 2001, and as President of Pfizer Pharmaceuticals Group from January 1997 to April 2001. Dr. McKinnell served as Chief Operating Officer of Pfizer Inc. from May 1999 to December 2000 and as Executive Vice President from 1992 to 1999. Dr. McKinnell currently is the Chairman of the board of Emmaus Life Sciences, Inc. (member of the board from May 2010—present) and the Accordia Global Health Foundation (member of the board from September 2003-present). He is Chairman Emeritus of the Connecticut Science Center and is a member of the Academic Alliance for AIDS Care and Prevention in Africa. He served as Chairman of Optimer Pharmaceuticals, Inc. until 2013 and director of Angiotech Pharmaceuticals, Inc. until 2011, Pfizer Inc. and ExxonMobil Corporation until 2007 and John Wiley & Sons until 2005.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Henry McKinnell

--

Raymond McDaniel

8,411,990

Linda Huber

3,206,230

Mark Almeida

2,329,950

Michel Madelain

2,630,530

Lisa Westlake

--
As Of 30 Dec 2013
Search Stocks